Workflow
理文化工(00746) - 2019 - 中期财报
L & M CHEMICALL & M CHEMICAL(HK:00746)2019-08-21 08:55

Financial Performance - Revenue for the six months ended June 30, 2019, was HK$1,718,656,000, a decrease of 11.98% from HK$1,953,247,000 in the same period of 2018[9] - Gross profit for the period was HK$682,093,000, down 28.38% from HK$952,419,000 in the previous year[9] - Profit for the period attributable to owners of the Company was HK$401,180,000, a decrease of 26.39% compared to HK$545,354,000 in 2018[10] - Basic earnings per share for the period was 48.6 HK cents, down from 66.1 HK cents in the same period last year[10] - Total comprehensive income for the period attributable to owners of the Company was HK$392,015,000, compared to HK$534,754,000 in 2018, reflecting a decline of 26.67%[10] - The profit for the period was impacted by a decrease in directors' emoluments to HK$26,027 from HK$27,378, a reduction of 4.9%[43] - The Group's net profit for the same period was approximately HK$401 million, representing a decrease of 26.4% year-on-year[92] Income and Expenses - Other income increased to HK$85,426,000 from HK$44,797,000, representing an increase of 90.67% year-on-year[9] - Finance costs decreased to HK$41,027,000 from HK$45,279,000, indicating a reduction of 9.93%[9] - The Group's current tax expense for the period was HK$61,554, down 37.9% from HK$99,093 in the same period of 2018[42] - Total staff costs increased to HK$153,506 from HK$145,480, reflecting a rise of 5.5%[43] - Selling and distribution expenses were approximately HK$107 million, representing 6.2% of total revenue, an increase from 5.6% in the previous period[95] - General and administrative expenses decreased to approximately HK$84 million, representing 4.9% of total revenue, compared to 5.4% in the same period last year[96] Assets and Liabilities - As of June 30, 2019, total assets less current liabilities amounted to HK$4,652,309,000, an increase from HK$4,513,593,000 as of December 31, 2018, reflecting a growth of approximately 3.1%[12] - Net current assets decreased to HK$138,033,000 from HK$194,857,000, indicating a decline of about 29.2%[12] - The company's net assets increased to HK$3,763,196,000, up from HK$3,478,665,000, representing a growth of approximately 8.2%[12] - Bank borrowings due within one year rose to HK$1,045,963,000 from HK$926,519,000, an increase of about 12.9%[12] - Inventories decreased significantly to HK$414,003,000 from HK$585,919,000, a reduction of approximately 29.3%[12] - Total trade and other payables amounted to HK$393.41 million, a decrease from HK$425.46 million at the end of 2018[59] Cash Flow - Net cash from operating activities for the six months ended June 30, 2019, was HK$538,230,000, an increase of 15.1% compared to HK$467,306,000 for the same period in 2018[14] - Net cash used in investing activities amounted to HK$352,052,000, up from HK$257,981,000 in the previous year, reflecting a significant increase in investment expenditures[14] - Net cash used in financing activities decreased to HK$185,782,000 from HK$317,382,000, indicating improved cash flow management in financing[14] - Cash and cash equivalents at the end of the period were HK$591,245,000, compared to HK$333,479,000 at the end of the same period last year, representing a substantial increase of 77.3%[14] - Dividends paid decreased to HK$123,750,000 from HK$165,000,000, reflecting a more conservative approach to cash distribution[14] Shareholder Information - As of June 30, 2019, Ms. Kwok Ching Yee Lorinda holds 495,000,000 shares, representing 60% of the issued share capital of the Company[115] - Dr. Lee Wan Keung Patrick holds 123,750,000 shares, representing 15% of the issued share capital of the Company[115] - The Company declared an interim dividend of HK$0.18 per share for the six months ended June 30, 2019, down from HK$0.23 per share in 2018, totaling HK$148.5 million compared to HK$189.75 million in the previous year[46] Compliance and Governance - The Company has complied with the Corporate Governance Code throughout the six months ended June 30, 2019[118] - All members of the Board confirmed compliance with the Model Code for Securities Transactions throughout the six months ended June 30, 2019[117] - The Audit Committee reviewed the Group's unaudited interim results for the six months ended June 30, 2019[119] - The Remuneration Committee and Nomination Committee have been established in compliance with the Code, consisting of independent non-executive directors[120][121] Strategic Initiatives - The Company continues to focus on enhancing its product offerings and market expansion strategies to drive future growth[8] - The Group plans to begin sales of commercialized hydrogen in the third quarter of 2019, contributing to the development of hydrogen fuel cells[87] - Trial production of internally-developed lithium battery electrolyte additives is expected to begin in December 2019[87] - The company continues to invest in production automation and intelligent management to counter rising human resource costs[88]